Question 1

What are the potential side effects of pirtobrutinib?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma clinical trial (NCT07218341). Contact the study team or your healthcare provider for specific answers.

Question 2

How often will I need to come in for treatment and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma clinical trial (NCT07218341). Contact the study team or your healthcare provider for specific answers.

Question 3

What should I expect during the study in terms of monitoring my health?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma clinical trial (NCT07218341). Contact the study team or your healthcare provider for specific answers.

Question 4

How does this treatment compare to other options I may have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma clinical trial (NCT07218341). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma clinical trial (NCT07218341). Contact the study team or your healthcare provider for specific answers.

Question 6

Is there any cost associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma clinical trial (NCT07218341). Contact the study team or your healthcare provider for specific answers.

What this study is about